Doric Nimrod Air One launched back in 2010. The idea behind the aircraft-leasing fund was to buy an Airbus A380 and lease it to Emirates for an initial term of 12 years. That lease and the resulting lease payments would help fund a wedge of debt (initially $122m) plus equity that paid a dividend of 9p a year.
At the end of the lease it was reasonable to assume the plane might undergo some renewal and then be leased out again. Aircraft-leasing funds seemed compelling options for specialist income investors. Doric Nimrod Two and Three duly followed, with the same structure but more aircraft. Amadeo Air Four Plus was a similar fund with a slightly different structure and different planes.
The pandemic’s effect
Then the coronavirus hit. Demand for global travel collapsed, and suddenly the entire point of huge super planes such as the A380 was called into question. Airbus eventually decided to stop building them and what little demand there was collapsed. Airlines continue to fly them, but if you own an A380 that is coming out of lease, everything has changed. Pre-pandemic there was a reasonable expectation that at the end of the lease term these planes might have residual value. But while specialist appraisers might be able to estimate the residual value of a plane as it drops out of lease, market prices are needed to get a true gauge. The difference between the appraised and market residual value is the key issue in the valuation of these aircraft-leasing funds.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Roughly speaking, the funds are already talking about a 75% cut to the last appraisal (as of March 2021), which implies a residual value of roughly $45m per plane. But the current share prices of the Nimrod funds suggest a true value closer to $12m per plane, down around 90%. Even that may be too high if they have to be sold for parts or scrap metal.
That said, things have become slightly clearer in recent weeks. Emirates has told Doric Nimrod Air Two that it will exercise its option to re-deliver a plane in “half-life” return condition (as opposed to “fulllife” – which is the equivalent of a plane that has just had a full service). Emirates will pay the fund an extra $12m at lease expiry should it choose to return the aircraft early.
This provides at least one anchor for that $12m residual value, and the fund continues to get the lease payments until the end of the contract. There might even be some upside to the planes if and when they are sold for parts. If the market is right and the planes are worth $12m, the funds could prove to be a good deal, reckons Matt Hose at Jefferies.
If they wind up around 2024, having paid off their debts and worked out what to do with the planes, then the internal rate of return (before costs) could be roughly 18% a year over the next few years. Amadeo Air Four Plus was always more complicated.
It launched later than the Nimrod funds and has a mixed portfolio of plane types. It has had to renegotiate deals with its airlines, probably at reduced rates. But it’s sitting on more than £100m in cash from earlier deals and is reinstating its quarterly dividend at 1.25p per share, a target yield of 16.9%. There’s less disclosure on the underlying financials but that dividend looks fairly secure.
Not worth the hassle
Complex financial engineering involving expensive leased assets producing a regular income sounds attractive until events change the landscape. On top of the pandemic many private equity-based aircraft funds now have to cope with the Ukraine invasion, with planes leased to Russian airlines stuck on the tarmac.
And it’s all very well having a financial plan that depends on an asset having residual value in years to come, but how can you know what its value will be? In short, these asset-backed structures may be too complex and have too many working parts for most investors.
-
‘I installed a heat pump in my home – here are five things I’ve learnt’From the size and noise of a heat pump to how much it costs to run one, Ruth Emery reveals what she’s learnt after installing one in her home six months ago
-
3 ways to work out if a stock is good valueThe only thing you can really control in investing is the price you pay for an asset – but how can you tell if you’re getting a good deal when it comes to the price of a stock?
-
Two ways to tap into monopoly profits from airportsMost investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?The latest weight-loss treatments could transform public health and the world economy. Should you invest?
-
How investors could profit from Ramsden Holdings' four-part growth strategyRamsdens Holdings offers a diversified set of financial and retail services and a juicy yield, says Dr Michael Tubbs
-
How to invest in the booming insurance marketThe insurance sector is experiencing rapid growth after years of stagnation. Smart investors should buy in now, says Rupert Hargreaves
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocksOpinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
-
BP's 'long, painful decline' – and why next year could be even tougherOpinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global marketsOpinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
-
Falling revenues and mounting debt spell trouble for Jumia TechnologiesStruggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
